DTI for Injection

DTI for Injection

dacarbazine

Manufacturer:

Korea United Pharm [KR]

Distributor:

Masu
Concise Prescribing Info
Contents
Dacarbazine
Indications/Uses
Metastatic malignant melanoma. 2nd-line therapy for Hodgkin's disease in combination w/ other effective agents.
Dosage/Direction for Use
Max: 200 mg/m2 as slow IV inj. Doses ranging from 200-850 mg/m2 should be administered as IV infusion over 15-30 min. Hodgkin's disease In combination w/ other effective drugs: 150 mg/m2/day for 5 days. May be repeated every 4 wk. Alternatively, 375 mg/m2 on Day 1 repeated every 15 days. Malignant melanoma Recommended dose: 2-4.5 mg/kg/day for 10 days. May be repeated at 4 wk intervals. Alternatively, 250 mg/m2/day IV for 5 days, repeated every 3 wk.
Contraindications
History of hypersensitivity. Patients w/ leucopenia &/or thrombocytopenia, severe liver or kidney diseases. Pregnancy & lactation.
Special Precautions
Bone marrow suppression, leukopenia, thrombocytopenia, anemia may occur; monitor CBC w/ differential. Hepatic necrosis; hepatotoxicity w/ hepatic vein thrombosis & hepatocellular necrosis. Antiemetics are recommended. Extravasation & hypersensitivity reactions may occur. Severe GI reactions may occur. Renal & hepatic impairment. Avoid skin & eye contact during reconstitution or administration. Avoid hepatotoxic drugs & alcohol during chemotherapy. Pregnancy & lactation.
Adverse Reactions
Anemia, leukopenia & thrombocytopenia; anorexia, nausea & vomiting.
Drug Interactions
Drugs metabolised by CYP450 (CYP1A1, CYP1A2 & CYP2E1) & oral anticoagulants. May enhance effects of methoxypsoralen. Risk of serious & potentially fatal infections w/ live vaccines. Reduced absorption of phenytoin. May cause excessive immunosuppression & lymphoproliferation w/ cyclosporine & tacrolimus. May cause acute pulmonary toxicity (adult resp distress syndrome) w/ fotemustine.
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01AX04 - dacarbazine ; Belongs to the class of other alkylating agents. Used in the treatment of cancer.
Presentation/Packing
Form
DTI for Injection inj 100 mg
Packing/Price
1's
Form
DTI for Injection inj 200 mg
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in